Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRVS | A | Corvus Pharmaceuticals, Inc. | 2.94 | |
ARGX | A | argenx SE | 1.58 | |
CKPT | A | Checkpoint Therapeutics, Inc. | 2.03 | |
GNTA | A | Genenta Science S.p.A. | 6.86 | |
ADAG | A | Adagene Inc. | 5.26 | |
ZYME | B | Zymeworks Inc. | -3.07 | |
IOVA | B | Iovance Biotherapeutics, Inc. | 7.18 | |
ACHL | B | Achilles Therapeutics plc | 2.00 | |
XLO | B | Xilio Therapeutics, Inc. | 3.94 | |
IBRX | B | ImmunityBio, Inc. | 1.34 |
Related Industries: Biotechnology Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EWK | D | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
BBH | D | Market Vectors Biotech ETF | 4.6 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 4.21 | |
CANC | C | Tema Oncology ETF | 3.87 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 3.66 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles